Skip to content
B
BiotechEdge
Start 14-Day Free Trial

iTeos Therapeutics + Concentra Biosciences

closed

$ITOS acquired by Concentra Biosciences for $236M

Deal Summary

Deal Value
$236M
Price/Share
$10.05
Announced
Jul 21, 2025
Closed
Aug 29, 2025

Fund Positioning

4 of 20 tracked specialist biotech funds held $ITOS — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
EcoR1 Capital10.7M$106.6MJun 2025Yes
RA Capital Management3.6M$21.8MMar 2025Yes
BVF Partners3.1M$18.4MMar 2025Yes
OrbiMed Advisors700K$7.0MJun 2025Yes
← All biotech acquisitions